In an effort to support global initiatives to contain the spread of the new coronavirus (COVID-19), the Academy is moving to an online platform or postponing all meetings and events intended to be held in person through April 30, 2020. Please check here for more information, including Academy programs on COVID-19, and links to the latest advisories from public health officials.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

Annals

Signal Transduction Pathways, Part B

Edited by Edited by Marc Diederich (Fondation "Recherche sur le Cancer et les Maladies du Sang", Hôpital Kirchberg, Luxembourg)
Signal Transduction Pathways, Part B

Published: December 2006

Volume 1091

Learn More

These volumes focus on the therapeutic potential for targeting cell signaling mechanisms with particular attention to cancer therapies and inflammatory signaling pathways as well as immunomodulation. Part B focuses on basic research, and the chapters are divided into the following sections: oxidative stress, transcriptional control, HDAC, and novel technological and therapeutic approaches.